Corrigendum to “Mild photothermal therapy/photodynamic therapy/chemotherapy of breast cancer by Lyp-1 modified docetaxel/IR820 co-loaded micelles”[Biomaterials, 106 (2016) 119–133] (Biomaterials (2016) 106 (119–133), (S0142961216304021), (10.1016/j.biomaterials.2016.08.016));Mild photothermal therapy/photodynamic therapy/chemotherapy of breast cancer by Lyp-1 modified Docetaxel/IR820 Co-loaded micelles

Biomaterials

Volumn 106, Issue , 2016, Pages 119-133

  Li, WenTing ^a   Peng, JinRong ^a   Tan, LiWei ^a   Wu, Jing ^a   Shi, Kun ^a   Qu, Ying ^a   Wei, XiaWei ^a   Qian, ZhiYong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cancer therapy; Chemotherapy; Micelle; Photodynamic therapy; Photothermal therapy

Indexed keywords

CHEMOTHERAPY; DISEASES; INFRARED DEVICES; MAMMALS; MEDICAL NANOTECHNOLOGY; MICELLES; NANOSYSTEMS; TUMORS;

ACTIVE TARGETING; CANCER THERAPY; COMBINATION THERAPY; NEGATIVE CHARGE; PHOTO-THERMAL CONVERSIONS; PHOTOTHERMAL THERAPY; STATIC INTERACTION; TUMOR TARGETING;

PHOTODYNAMIC THERAPY;

DOCETAXEL; DYE; IR 820; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CYCLOPEPTIDE; INDOCYANINE GREEN; LYP-1 PEPTIDE; NANOCAPSULE; PHOTOSENSITIZING AGENT; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; MICELLE; MOUSE; NANOMEDICINE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; TUMOR CELL; ANALOGS AND DERIVATIVES; ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CHEMISTRY; EMULSION; FEMALE; INFRARED RADIATION; METABOLISM; MOLECULARLY TARGETED THERAPY; MULTIMODALITY CANCER THERAPY; NUDE MOUSE; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; THERAPEUTIC USE; THERMOTHERAPY; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; EMULSIONS; FEMALE; HYPERTHERMIA, INDUCED; INDOCYANINE GREEN; INFRARED RAYS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICELLES; MOLECULAR TARGETED THERAPY; NANOCAPSULES; PEPTIDES, CYCLIC; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; TAXOIDS; TREATMENT OUTCOME;

EID: 84983384754     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2020.120375     Document Type: Erratum

References (28)

1. [1] Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics. CA A Cancer J. Clin. 65:1 (2015), 5–29.
2. [2] Rubin, P., Carter, S.K., Combination radiation therapy and chemotherapy: a logical basis for their clinical use. CA A Cancer J. Clin. 26:5 (1976), 274–292.
3. [3] Park, J., Wrzesinski, S.H., Stern, E., Look, M., Criscione, J., Ragheb, R., et al. Combination delivery of TGF-b inhibitor and IL-2 by Nanoscale liposomal polymeric gels enhances tumor immunotherapy. Nat. Mater. 11 (2012), 895–905.
4. [4] Wang, C., Xu, L., Liang, C., Xiang, J., Peng, R., Liu, Z., Immunological responses triggered by Photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis. Adv. Mater. 26:48 (2014), 8154–8162.
5. [5] Sun, X., Wang, C., Gao, M., Hu, A., Liu, Z., Remotely controlled red blood cell carriers for cancer targeting and near-infrared light-triggered drug release in combined Photothermal-chemotherapy. Adv. Fun Mater. 25 (2015), 2386–2394.
6. [6] Parhi, P., Mohanty, C., Sahoo, S.K., Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discov. Today 17 (2012), 1044–1052.
7. [7] Deng, H., Dai, F., Ma, G., Zhang, X., Theranostics gold nanomicelles made from biocompatible comb-like polymers for thermochemotherapy and multifunctional imaging with rapid clearance. Adv. Mater. 27:24 (2015), 3645–3653.
8. [8] He, Q., Guo, S., Qian, Z., Chen, X., Development of individualized anti-metastasis strategies by engineering nanomedicines. Chem. Soc. Rev. 44:17 (2015), 6258–6286.
9. [9] Huynh, E., Zheng, G., Engineering multifunctional nanoparticls: all-in-one versus one-for-all. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 5:3 (2013), 250–265.
10. [10] Lammers, T., Aime, S., Hennink, W.E., Storm, G., Kiessling, F., TheranosticNanomedicine. Account Chem. Res. 44:10 (2011), 1029–1038.
11. [11] Hu, M., Chen, J., Li, Z., Au, L., Harland, G.V., Li, X., et al. Gold nanostructures: engineering their plasmonic properties for biomedical applications. Chem. Soc. Rev. 35:11 (2006), 1084–1094.
12. [12] Huang, X., Tang, S., Mu, X., Dai, Y., Chen, G., Zhou, Z., et al. Freestanding palladium nanosheets with plasmonic and catalytic properties. Nat. Nanotechnol. 6 (2011), 28–32.
13. [13] Yang, K., Zhang, S., Zhang, G., Sun, X., Lee, S., Liu, Z., Graphene in mice: ultrahigh in vivo tumor uptake and efficient Photothermal therapy. NanoLett 10:9 (2010), 3318–3323.
14. [14] Goel, S., Chen, F., Cai, W., Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics. Small 10:4 (2014), 631–645.
15. [15] Fubini, B., Ghiazza, M., Fenoglio, I., Physico-chemical features of engineered nanoaprticles relevant to their toxicity. Nanotoxicol 4:4 (2010), 347–363.
16. [16] Chen, Q., Liang, C., Wang, C., Liu, Z., An imagable and Photothermal “Abraxane-like” nanodrug for combination cancer therapy to treat subcutaneous and metastatic breast tumors. Adv. Mater. 27 (2015), 903–910.
17. [17] Huang, P., Rong, P., Jin, A., Yan, X., Zhang, M.G., Lin, J., et al. Dye-loaded ferritin nanocages for multimodal imaging and Photothermal therapy. Adv. Mater. 26 (2014), 6401–6408.
18. [18] Sheng, Z., Hu, D., Zheng, M., Zhao, P., Liu, H., Gao, D., et al. Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging –guided cancer synergistic phototherapy. ACS Nano 8:12 (2014), 12310–12322.
19. [19] Wang, Y., Wang, C., Wang, Y., Luo, Feng, Yan, X., Qian, Z., Micelles of methoxypoly(ethylene glycol)-poly(epsilon-caprolactone) as a novel drug delivery vehicle for Tacrolimus. J. Biomed. Nanotechnol. 9:2 (2013), 147–157.
20. [20] Wang, Y., Chen, L., Tan, L., Zhao, Q., Luo, F., Wei, Y., et al. PEG-PCL based micelle hydrogels as oral docetaxel delivery systems for breast cancer therapy. Biomaterials 35:25 (2014), 6972–6985.
21. [21] Peng, J., Qi, T., Liao, J., Chu, B., Yang, Q., Li, W., et al. Controlled release of cisplatin from pH/thermal responsive nanogels. Biomaterials 34 (2013), 8726–8740.
22. [22] Jin, X.X., Wang, Y.L., Tan, L.W., He, Y., Peng, J.R., Hai, L., et al. An efficient injectable formulation with block copolymer micelles for hydrophobic antitumor candidate-pyridazinone derivatives. Nanomedicine 10:14 (2015), 2153–2165.
23. [23] Peng, J., Qi, T., Liao, J., Chu, B., Yang, Q., Qu, Y., et al. Mesoporous magnetic gold “Nanoclusters” as theranostic carrier for chemo-photothermal co-therapy of breast cancer. Theranostics 4:7 (2014), 678–692.
24. [24] Liao, J., Li, W., Peng, J., Yang, Q., Li, H., Wei, Y., et al. Combined cancer Photothermal-chemotherapy based on doxorubicin/gold nanorod-loaded polymersomes. Theranostics 5:4 (2015), 345–356.
25. [25] Field, L.D., Delehanty, J.B., Chen, Y.C., Medintz, I.L., Peptides for specifically targeting nanoparticles to cellular organelles: quo vadis?. Acc. Chem. Res. 48:5 (2015), 1380–1390.
26. [26] Laakkonen, P., Porkka, K., Hoffman, J.A., Ruoslahti, E., A tumor-homing peptide with a targeting specificity related to lymphatic vessels. Nat. Med. 8 (2002), 751–755.
27. [27] Chen, Q., Wang, X., Wang, C., Feng, L., Li, Y., Liu, Z., Drug-induced self-assembly of modified albumins as nano-theranostics for tumor-targeted combination therapy. ACS Nano 9:5 (2015), 5223–5233.
28. [28] Hildebrandt, B., Wust, P., Ahlers, O., Dieing, A., Sreenivasa, G., Kerner, T., et al. The cellular and molecular basis of hyperthermia. Crit. Rev. OncolHemat 43 (2002), 33–56.